99
Kindstar Globalgene Technology, Inc.
9960.HK · HKSE
$0.95 +2.72% (+$0.03)
1M +0.00%
Market Cap ¥821.1M
P/E Ratio -
Div. Yield -
ROE 2.16%
Bulios Fair Price
$0.54
42.9% downside
Current Price
$0.95
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 9960.HK is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
84 /100
Cheap P/FCF 18.83x
P/S 0.88x
P/B 0.30x
Growth
4 /100
Declining Book val. growth 1.14%
Rev. growth 12.35%
FCF growth N/A
Profitability
28 /100
Weak Op. margin 11.89%
Gross margin 44.07%
FCF margin 4.67%
Quality
3 /100
Poor ROA 1.56%
ROIC 4.70%
Asset turnover 0.25x
Debt
69 /100
Low Int. coverage -11.72x
Debt/Equity 0.16x
Current ratio 2.81x
Stability
46 /100
Moderate EPS volatility 122.52%
Beta 0.64x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 9960.HK
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Shiang Huang
Employees
2,999
Headquarters
Wuhan
Upcoming events
26 MAR
Earnings
Upcoming earnings report